Open access · CC-BY
via OpenAlex
Progress of mesenchymal stem cell therapy for neural and retinal diseases
Tsz Kin Ng, Veronica R Fortino, Daniel Pelaez, Herman S Cheung
World Journal of Stem Cells · 2014 · ▲ 124 citations
Abstract
Complex circuitry and limited regenerative power make central nervous system (CNS) disorders the most challenging and difficult for functional repair. With elusive disease mechanisms, traditional surgical and medical interventions merely slow down the progression of the neurodegenerative diseases. However, the number of neurons still diminishes in many patients. Recently, stem cell therapy has been proposed as a viable option. Mesenchymal stem cells (MSCs), a widely-studied human adult stem cell population, have been discovered for more than 20 years. MSCs have been found all over the body and can be conveniently obtained from different accessible tissues: bone marrow, blood, and adipose and dental tissue. MSCs have high proliferative and differentiation abilities, providing an inexhaustible source of neurons and glia for cell replacement therapy. Moreover, MSCs also show neuroprotective effects without any genetic modification or reprogramming. In addition, the extraordinary immunomodulatory properties of MSCs enable autologous and heterologous transplantation. These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders. Here, we summarize the latest progress of MSC experimental research as well as human clinical trials for neural and retinal diseases. This review article will focus on multiple sclerosis, spinal cord injury, autism, glaucoma, retinitis pigmentosa and age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4252/wjsc.v6.i2.111
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Ng, T.K., Fortino, V.R., Pelaez, D., & Cheung, H.S. (2014). Progress of mesenchymal stem cell therapy for neural and retinal diseases. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.v6.i2.111
Vancouver
Ng TK, Fortino VR, Pelaez D, Cheung HS. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World Journal of Stem Cells. 2014. doi:10.4252/wjsc.v6.i2.111.
BibTeX
@article{tsz2014Progre,
title = {Progress of mesenchymal stem cell therapy for neural and retinal diseases},
author = {Tsz Kin Ng and Veronica R Fortino and Daniel Pelaez and Herman S Cheung},
journal = {World Journal of Stem Cells},
year = {2014},
doi = {10.4252/wjsc.v6.i2.111},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Smart Medicine 2022
Open access · CC-BY
Reprogramming stem cells in regenerative medicine
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Biotechnology Advances 2013
Open access · CC-BY
Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction
Aging and Disease 2023
Open access · CC-BY
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies
Apmis 2005
Open access · OA
Neural transdifferentiation of mesenchymal stem cells – a critical review
Sultan Qaboos University medical journal 2018
Open access · CC-BY